Piper Sandler Reiterates Overweight on Alpha Tau Medical, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has reiterated an Overweight rating on Alpha Tau Medical (NASDAQ:DRTS) but lowered the price target from $8 to $7.
March 08, 2024 | 2:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on Alpha Tau Medical but reduced the price target from $8 to $7.
The reduction in price target by Piper Sandler, despite maintaining an Overweight rating, could lead to short-term negative sentiment among investors, potentially impacting the stock price negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100